Cochrane Abstracts
Additional bedtime H2‐receptor antagonist for the control of nocturnal gastric acid breakthrough
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Additional Bedtime H2‐receptor Antagonist for the Control of Nocturnal Gastric Acid Breakthrough." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Additional_bedtime_H2‐receptor_antagonist_for_the_control_of_nocturnal_gastric_acid_breakthrough.
Additional bedtime H2‐receptor antagonist for the control of nocturnal gastric acid breakthrough. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Additional_bedtime_H2‐receptor_antagonist_for_the_control_of_nocturnal_gastric_acid_breakthrough. Accessed January 24, 2026.
Additional bedtime H2‐receptor antagonist for the control of nocturnal gastric acid breakthrough. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Additional_bedtime_H2‐receptor_antagonist_for_the_control_of_nocturnal_gastric_acid_breakthrough
Additional Bedtime H2‐receptor Antagonist for the Control of Nocturnal Gastric Acid Breakthrough [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Additional_bedtime_H2‐receptor_antagonist_for_the_control_of_nocturnal_gastric_acid_breakthrough.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Additional bedtime H2‐receptor antagonist for the control of nocturnal gastric acid breakthrough
ID - 437974
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437974/all/Additional_bedtime_H2‐receptor_antagonist_for_the_control_of_nocturnal_gastric_acid_breakthrough
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
